DRUG · Unmapped registry intervention
APL-130277
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Examine APL-130277 in Patients With Parkinson's Disease
NCT02228590
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Examine APL-130277 in Patients With Parkinson's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson's Diseaseverified · MONDO: Parkinson disease
Interventions
APL-130277DRUG
Sponsors & collaborators
Sumitomo Pharma America, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02228590 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.